BeiGene (ONC) Shareholders Equity

Annual Shareholders Equity

$3.54 B
-$846.03 M-19.30%

December 1, 2023


Summary


Performance

ONC Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCbalance sheetmetrics:

Quarterly Shareholders Equity

$3.44 B
+$69.82 M+2.07%

September 1, 2024


Summary


Performance

ONC Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ONC Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.3%-2.9%
3 y3 years-8.6%-21.6%
5 y5 years+103.4%-21.6%

ONC Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-42.3%at low-44.0%+2.3%
5 y5-year-42.3%+267.6%-44.0%+257.1%
alltimeall time-42.3%+9234.2%-44.0%>+9999.0%

BeiGene Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$3.44 B(+2.1%)
Jun 2024
-
$3.37 B(+0.2%)
Mar 2024
-
$3.36 B(-5.0%)
Dec 2023
$3.54 B(-19.3%)
$3.54 B(-6.0%)
Sep 2023
-
$3.76 B(-0.9%)
Jun 2023
-
$3.80 B(-8.6%)
Mar 2023
-
$4.16 B(-5.2%)
Dec 2022
$4.38 B(-28.5%)
$4.38 B(-5.8%)
Sep 2022
-
$4.66 B(-12.2%)
Jun 2022
-
$5.30 B(-9.9%)
Mar 2022
-
$5.89 B(-4.0%)
Dec 2021
$6.13 B(+58.5%)
$6.13 B(+82.7%)
Sep 2021
-
$3.36 B(-6.9%)
Jun 2021
-
$3.61 B(-9.9%)
Mar 2021
-
$4.00 B(+3.5%)
Dec 2020
$3.87 B(+302.1%)
$3.87 B(-9.8%)
Sep 2020
-
$4.29 B(+69.0%)
Jun 2020
-
$2.54 B(-9.8%)
Mar 2020
-
$2.81 B(+192.3%)
Dec 2019
$962.21 M
$962.21 M(-24.7%)
DateAnnualQuarterly
Sep 2019
-
$1.28 B(-17.7%)
Jun 2019
-
$1.55 B(-3.4%)
Mar 2019
-
$1.61 B(-7.5%)
Dec 2018
$1.74 B(+159.7%)
$1.74 B(-11.7%)
Sep 2018
-
$1.97 B(+62.4%)
Jun 2018
-
$1.21 B(-9.8%)
Mar 2018
-
$1.34 B(+100.7%)
Dec 2017
$669.81 M(+89.8%)
$669.81 M(-10.7%)
Sep 2017
-
$750.14 M(+193.3%)
Jun 2017
-
$255.75 M(-17.1%)
Mar 2017
-
$308.42 M(-12.6%)
Dec 2016
$352.91 M(+374.9%)
$352.91 M(+87.9%)
Sep 2016
-
$187.83 M(-14.6%)
Jun 2016
-
$220.05 M(-9.5%)
Mar 2016
-
$243.10 M(+227.1%)
Dec 2015
$74.32 M(+188.4%)
$74.32 M(-25.7%)
Sep 2015
-
$100.08 M(-8.9%)
Jun 2015
-
$109.91 M(+326.5%)
Dec 2014
$25.77 M(-166.5%)
$25.77 M
Dec 2013
-$38.73 M
-

FAQ

  • What is BeiGene annual stockholders equity?
  • What is the all time high annual shareholders equity for BeiGene?
  • What is BeiGene annual shareholders equity year-on-year change?
  • What is BeiGene quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for BeiGene?
  • What is BeiGene quarterly shareholders equity year-on-year change?

What is BeiGene annual stockholders equity?

The current annual shareholders equity of ONC is $3.54 B

What is the all time high annual shareholders equity for BeiGene?

BeiGene all-time high annual stockholders equity is $6.13 B

What is BeiGene annual shareholders equity year-on-year change?

Over the past year, ONC annual stockholders equity has changed by -$846.03 M (-19.30%)

What is BeiGene quarterly stockholders equity?

The current quarterly shareholders equity of ONC is $3.44 B

What is the all time high quarterly shareholders equity for BeiGene?

BeiGene all-time high quarterly stockholders equity is $6.13 B

What is BeiGene quarterly shareholders equity year-on-year change?

Over the past year, ONC quarterly stockholders equity has changed by -$101.25 M (-2.86%)